Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | Date | No Grouping
Jump to: 2022 | 2018
Number of items: 2.

2022

Loibl, S., Untch, M., Burchardi, N., Huober, J., Sinn, B. V., Blohmer, J. -U., Grischke, E. -M., Furlanetto, J., Tesch, H., Hanusch, C., Engels, K., Rezai, M., Jackisch, C., Schmitt, W. D., von Minckwitz, G., Thomalla, J., Kuemmel, S., Rautenberg, B., Fasching, P. A., Weber, K., Rhiem, K., Denkert, C. and Schneeweiss, A. (2022). A randomised phase II study investigating durvalumab in addition to an anthracycline taxane-based neoadjuvant therapy in early triple-negative breast cancer: clinical results and biomarker analysis of GeparNuevo study (vol 30, pg 1279, 2019). Ann. Oncol., 33 (7). S. 743 - 745. AMSTERDAM: ELSEVIER. ISSN 1569-8041

2018

Rhiem, K., Wesselmann, S., Mensah, J., Bick, U., Blohmer, J. -U., du Bois, A., Emons, G., Gaissmaier, W., Hahne, A., Koch, K., Meindl, A., Scharl, A. J., Brigitte, S. and Schmutzler, R. K. (2018). Education Program of the German Consortium for Hereditary Breast and Ovarian Cancer and the German Cancer Sociey to improve genetic literacy and trans-sectoral cooperation in the Genome era. Oncol. Res. Treat., 41. S. 183 - 184. BASEL: KARGER. ISSN 2296-5262

This list was generated on Thu Mar 28 19:16:15 2024 CET.